Surf_Science

Couldn't you just pay a university laboratory, with hands on experience with murine infection with HIV, experienced personal, and already in possession of likely superior lab equipment (60k seems rather low for a FACS machine).

What you're describing seems like it could be accomplished in a couple of weeks by a lab that already had the equipment and expertise necessary.

If you don't mind. Who are the first and last authors on the manuscript?

Dr. Gupta, I'm a doctoral candidate in McGill Universities Centre for the Study of Host Resistance studying bacterial infection.

Given that

a) Multi-drug resistant bacteria seem to be endemic to the hospital setting, not private clinics, schools etc where we would see much of the overprescription (antibiotics for viral infections) and

b) Repeated prescription of the similar antibiotics (ex Amoxicillin) in the case of over prescription should not lead to resistance to other classes of antibiotics, the resistance which is at the heart of this problem.

Do you really think the heart of the problem lies with over prescription by GPs, or perhaps could the necessary use of antibiotics in the hospital setting be the at the core of this problem.

Thank you for your time.

I hi Jorge,

What can we in the infectious disease research community do to support you?

Thanks,

Thank you very much for answering my question. I'll have to look into Bio Surplus!

If you don't mind me asking are you planning or renting lab space from a facility that provides space for independent researchers like your team, or will you be setting up your own laboratory from scratch.

If your starting your own laboratory from scratch, are finding the process relatively easy or have you found the regulation and certification etc to be burdensome?

I ask because I am finishing my PhD in the next few months and am in the process of founding my own Biotechnology company, and so will be faced with the same decision that your company has, is, or has already made.

Thank you very much for your time!